Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received 177 Lu PSMA I&T therapy.
- Resource Type
- Article
- Source
- Hellenic Journal of Nuclear Medicine; Sep-Dec2020, Vol. 23 Issue 3, p229-239, 11p
- Subject
- Language
- ISSN
- 11081430